Updated:
Cancer Fund
Cancer Fund is a venture capital firm based in Phoenix, Arizona. It invests in biotechnology companies focused on cancer therapies, including melanoma.
Cancer Fund
Cancer Fund is a venture capital firm based in Phoenix, Arizona. It invests in biotechnology companies focused on cancer therapies, including melanoma. Cancer Fund has made 5 investments, with its latest being in Reglagene as part of their Series B on January 11, 2026.
General information
Firm type
Private Equity
Year founded
2018
Location
Region
North America
Country
United States
City
Phoenix
Corporate office
Phoenix, AZ, United States
Frequently asked questions
Does Cancer Fund participate in fund commitments or only direct deals?
No public information specifies whether Cancer Fund makes direct investments, fund commitments, or secondary purchases. The strategy label 'Private Equity' encompasses all of these structures, but the absence of portfolio disclosures means an allocator cannot verify the fund's actual deployment method.
Which sectors does Cancer Fund target or explicitly avoid?
The firm's strategy is classified as generalist venture. No sector preferences, thesis verticals, or explicit exclusions appear in any available source, making it difficult to determine whether the firm has built specialized domain expertise.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: